1-3 of 3
Greg Yanik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Clinical Trials & Observations
Sung Won Choi, Thomas Braun, Israel Henig, Erin Gatza, John Magenau, Brian Parkin, Attaphol Pawarode, Mary Riwes, Greg Yanik, Charles A. Dinarello, Pavan Reddy
Journal: Blood
Blood (2017) 130 (15): 1760–1767.
https://doi.org/10.1182/blood-2017-06-790469
Published: 2017
Journal Articles

Chronic Graft-Versus-Host Disease after Tacrolimus Versus Cyclosporine for Graft-Versus-Host Disease Prophylaxis in Pediatric Patients Undergoing Matched Unrelated Donor Hematopoietic Stem Cell Transplantation. A Pediatric Blood and Marrow Transplant Consortium Study. .

Mark P. Atlas, MD, Greg Yanik, MD, Kirk R. Schultz, MD, Rakesh K. Goyal, MD
Journal: Blood
Blood (2007) 110 (11): 4984.
https://doi.org/10.1182/blood.V110.11.4984.4984
Published: 2007
Journal Articles

Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.

Yasser Khaled, MD, Koji Kato, MD, John E. Levine, MD, Smitha Mellacheruvu, MD, Andrzej Jakubowiak, MD, Oleg Krijanovski, MD, Edward Peres, MD, Pavan Reddy, MD, Kevin Knott, Greg Yanik, MD, James Ferrara, MD, Shin Mineishi, MD
Journal: Blood
Blood (2007) 110 (11): 3031.
https://doi.org/10.1182/blood.V110.11.3031.3031
Published: 2007